Nagoya J Med Sci. 2025 May;87(2):374-379. doi: 10.18999/nagjms.87.2.374. ABSTRACT Innominate artery aneurysms are rare, accounting for only 0.26% of all aneurysms. Although usually asymptomatic, they …
Belitung Nurs J. 2025 Aug 3;11(4):478-486. doi: 10.33546/bnj.3816. eCollection 2025. ABSTRACT BACKGROUND: Integrated Management of Neonatal and Childhood Illness (IMNCI) is a critical strategy aimed …
Clin Case Rep. 2025 Aug 4;13(8):e70703. doi: 10.1002/ccr3.70703. eCollection 2025 Aug. ABSTRACT Cephalohematoma is a self-limiting lesion in 1%-2% of neonates. Cephalohematoma bleeds between the …
Cureus. 2025 Jul 5;17(7):e87324. doi: 10.7759/cureus.87324. eCollection 2025 Jul. ABSTRACT Spigelian-cryptorchidism syndrome is a rare and diagnostically challenging condition in neonatology that is characterized by …
Int J Med Sci. 2025 Jul 24;22(13):3429-3438. doi: 10.7150/ijms.96371. eCollection 2025. ABSTRACT Objective: This study aimed to evaluate the anti-inflammatory effects of alpha-bisabolol (AB) in …
Metab Syndr Relat Disord. 2025 Aug 5. doi: 10.1177/15578518251366372. Online ahead of print. ABSTRACT Background: Increasing maternal body mass index (BMI) represents a risk factor …
Pain Manag. 2025 Aug 6:1-8. doi: 10.1080/17581869.2025.2543232. Online ahead of print. ABSTRACT BACKGROUND: The primary objective of this randomized, double-blind, parallel-group trial is to evaluate …
Front Biosci (Landmark Ed). 2025 Jul 30;30(7):39676. doi: 10.31083/FBL39676. ABSTRACT BACKGROUND: Heart regeneration requires renewal of lost cardiomyocytes. However, the mammalian heart loses its proliferative …
Sci Rep. 2025 Aug 5;15(1):28587. doi: 10.1038/s41598-025-12199-w. ABSTRACT This study investigates the effects of bevacizumab, a common vascular endothelial growth factor (VEGF) inhibitor, in treating …
Pediatr Res. 2025 Aug 5. doi: 10.1038/s41390-025-04339-9. Online ahead of print. NO ABSTRACT PMID:40764395 | DOI:10.1038/s41390-025-04339-9
